OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)EuroSCORE IIFFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreReynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator

Clinical Evidence and Methodology

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Routinely in the initial assessment of patients presenting with acute myocardial infarction (AMI)
  • To rapidly stratify risk of 30-day and in-hospital mortality based purely on bedside clinical signs
  • To guide intensity of care (e.g., CCU admission vs. step-down unit)

Populations

Originally validated in the pre-reperfusion era (1967), but repeatedly validated in the modern era of primary PCI and potent antithrombotic therapy. Even though overall mortality rates have fallen, the predictive gradient across the four classes remains robust.

CLINICAL INSIGHT

How it Works

Classification Logic

  • Class I: Individuals with no clinical signs of heart failure. Typical mortality 6% (historical), now 2-3% in modern PCI eras.
  • Class II: Individuals with rales or crackles in the lungs, an S3 gallop, and elevated jugular venous pressure. Lung findings limited to the lower half of the lung fields. Typical mortality 17% (historical), now ~5-8%.
  • Class III: Individuals with frank acute pulmonary edema. Typical mortality 38% (historical), now ~10-15%.
  • Class IV: Individuals in cardiogenic shock or hypotension (systolic blood pressure < 90 mmHg), and evidence of peripheral vasoconstriction (oliguria, cyanosis or diaphoresis). Typical mortality 81% (historical), but remains extremely high today even with advanced MCS/ECMO (~40-50%).
CLINICAL INSIGHT

Practical Pearls

Subjectivity and Interobserver Reliability

The Killip classification is highly dependent on bedside physical examination skills, which have poor-to-moderate interobserver reliability among modern clinicians, especially for Class II vs Class III distinction. An S3 gallop can be difficult to auscultate in a noisy ED or CCU environment.

Integration with other scores

Because of its strong predictive power, the Killip class is incorporated directly into the GRACE score. A patient in Killip Class IV automatically receives a massive bump in their 6-month expected mortality in the GRACE model.

CLINICAL INSIGHT

Evidence Base

Original Publication

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Killip T 3rd, Kimball JT.Am J Cardiol.1967

Modern Validation

Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL.Am J Cardiol.2001
CLINICAL INSIGHT

Next Steps

Complementary Calculators

Killip Classification

Killip Classification: Stratifies risk of in-hospital mortality in patients with acute myocardial infarction based on clinical signs of heart failure.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Routinely in the initial assessment of patients presenting with acute myocardial infarction (AMI)
  • To rapidly stratify risk of 30-day and in-hospital mortality based purely on bedside clinical signs
  • To guide intensity of care (e.g., CCU admission vs. step-down unit)

Populations

Originally validated in the pre-reperfusion era (1967), but repeatedly validated in the modern era of primary PCI and potent antithrombotic therapy. Even though overall mortality rates have fallen, the predictive gradient across the four classes remains robust.

CLINICAL INSIGHT

How it Works

Classification Logic

  • Class I: Individuals with no clinical signs of heart failure. Typical mortality 6% (historical), now 2-3% in modern PCI eras.
  • Class II: Individuals with rales or crackles in the lungs, an S3 gallop, and elevated jugular venous pressure. Lung findings limited to the lower half of the lung fields. Typical mortality 17% (historical), now ~5-8%.
  • Class III: Individuals with frank acute pulmonary edema. Typical mortality 38% (historical), now ~10-15%.
  • Class IV: Individuals in cardiogenic shock or hypotension (systolic blood pressure < 90 mmHg), and evidence of peripheral vasoconstriction (oliguria, cyanosis or diaphoresis). Typical mortality 81% (historical), but remains extremely high today even with advanced MCS/ECMO (~40-50%).
CLINICAL INSIGHT

Practical Pearls

Subjectivity and Interobserver Reliability

The Killip classification is highly dependent on bedside physical examination skills, which have poor-to-moderate interobserver reliability among modern clinicians, especially for Class II vs Class III distinction. An S3 gallop can be difficult to auscultate in a noisy ED or CCU environment.

Integration with other scores

Because of its strong predictive power, the Killip class is incorporated directly into the GRACE score. A patient in Killip Class IV automatically receives a massive bump in their 6-month expected mortality in the GRACE model.

CLINICAL INSIGHT

Evidence Base

Original Publication

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Killip T 3rd, Kimball JT.Am J Cardiol.1967

Modern Validation

Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL.Am J Cardiol.2001
CLINICAL INSIGHT

Next Steps

Complementary Calculators